Design, synthesis, and evaluation of anxiolytic activity of 2-(4-phenylpiperazin-1-yl)-1H-benz[d]imidazole and 2-(4-phenylpiperazin-1-methyl)-1H-benz[d]imidazole derivatives
Background In contemporary society, anxiety has become a widespread disorder leading to compromised well-being and heightened depressive states. Extensive literature reviews indicate the diverse biological effects of benzimidazole and piperazine derivatives, notably their impact on the central nervo...
Saved in:
Published in | Future journal of pharmaceutical sciences Vol. 10; no. 1; pp. 50 - 9 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Berlin/Heidelberg
Springer Berlin Heidelberg
29.03.2024
Springer Nature B.V SpringerOpen |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background
In contemporary society, anxiety has become a widespread disorder leading to compromised well-being and heightened depressive states. Extensive literature reviews indicate the diverse biological effects of benzimidazole and piperazine derivatives, notably their impact on the central nervous system. This study aimed to design, molecularly dock, synthesize, and assess the anxiolytic potential of six derivatives of 2-(4-phenylpiperazin-1-yl)-1H-benz[d]imidazole and 2-(4-phenylpiperazin-1-methyl)-1H-benz[d]imidazole.
Results
In the present study, an attempt was made to synthesize benzimidazole derivatives conventionally. The benzimidazole nuclei are condensed with various substituted piperazines to obtain targeted benzimidazole–piperazine hybrids. Their anxiolytic activity is determined using the Elevated Plus Maze test and hole board test in mice. All compounds have shown good docking scores and in vivo anxiolytic activity.
Conclusion
Out of all the derivatives synthesized, compounds 5b, 5c, and 5f exhibited outstanding anxiolytic efficacy in both computational simulations and live subjects. Compound 5b demonstrated a remarkable docking score relative to the ligand, suggesting its potential as a promising candidate warranting further exploration. |
---|---|
AbstractList | Background
In contemporary society, anxiety has become a widespread disorder leading to compromised well-being and heightened depressive states. Extensive literature reviews indicate the diverse biological effects of benzimidazole and piperazine derivatives, notably their impact on the central nervous system. This study aimed to design, molecularly dock, synthesize, and assess the anxiolytic potential of six derivatives of 2-(4-phenylpiperazin-1-yl)-1H-benz[d]imidazole and 2-(4-phenylpiperazin-1-methyl)-1H-benz[d]imidazole.
Results
In the present study, an attempt was made to synthesize benzimidazole derivatives conventionally. The benzimidazole nuclei are condensed with various substituted piperazines to obtain targeted benzimidazole–piperazine hybrids. Their anxiolytic activity is determined using the Elevated Plus Maze test and hole board test in mice. All compounds have shown good docking scores and in vivo anxiolytic activity.
Conclusion
Out of all the derivatives synthesized, compounds 5b, 5c, and 5f exhibited outstanding anxiolytic efficacy in both computational simulations and live subjects. Compound 5b demonstrated a remarkable docking score relative to the ligand, suggesting its potential as a promising candidate warranting further exploration. Abstract Background In contemporary society, anxiety has become a widespread disorder leading to compromised well-being and heightened depressive states. Extensive literature reviews indicate the diverse biological effects of benzimidazole and piperazine derivatives, notably their impact on the central nervous system. This study aimed to design, molecularly dock, synthesize, and assess the anxiolytic potential of six derivatives of 2-(4-phenylpiperazin-1-yl)-1H-benz[d]imidazole and 2-(4-phenylpiperazin-1-methyl)-1H-benz[d]imidazole. Results In the present study, an attempt was made to synthesize benzimidazole derivatives conventionally. The benzimidazole nuclei are condensed with various substituted piperazines to obtain targeted benzimidazole–piperazine hybrids. Their anxiolytic activity is determined using the Elevated Plus Maze test and hole board test in mice. All compounds have shown good docking scores and in vivo anxiolytic activity. Conclusion Out of all the derivatives synthesized, compounds 5b, 5c, and 5f exhibited outstanding anxiolytic efficacy in both computational simulations and live subjects. Compound 5b demonstrated a remarkable docking score relative to the ligand, suggesting its potential as a promising candidate warranting further exploration. BackgroundIn contemporary society, anxiety has become a widespread disorder leading to compromised well-being and heightened depressive states. Extensive literature reviews indicate the diverse biological effects of benzimidazole and piperazine derivatives, notably their impact on the central nervous system. This study aimed to design, molecularly dock, synthesize, and assess the anxiolytic potential of six derivatives of 2-(4-phenylpiperazin-1-yl)-1H-benz[d]imidazole and 2-(4-phenylpiperazin-1-methyl)-1H-benz[d]imidazole.ResultsIn the present study, an attempt was made to synthesize benzimidazole derivatives conventionally. The benzimidazole nuclei are condensed with various substituted piperazines to obtain targeted benzimidazole–piperazine hybrids. Their anxiolytic activity is determined using the Elevated Plus Maze test and hole board test in mice. All compounds have shown good docking scores and in vivo anxiolytic activity.ConclusionOut of all the derivatives synthesized, compounds 5b, 5c, and 5f exhibited outstanding anxiolytic efficacy in both computational simulations and live subjects. Compound 5b demonstrated a remarkable docking score relative to the ligand, suggesting its potential as a promising candidate warranting further exploration. |
ArticleNumber | 50 |
Author | Unavane, Supriya Mahajan, Bhavna Sunil Kawale, Laxman A. Nade, Vandana S. Kapadnis, Prajakta Sajimon, Lida |
Author_xml | – sequence: 1 givenname: Bhavna Sunil orcidid: 0009-0000-1770-1100 surname: Mahajan fullname: Mahajan, Bhavna Sunil email: bhavnamahajan15@gmail.com organization: Pharmaceutical Chemistry Department, Vishwakarma University School of Pharmacy – sequence: 2 givenname: Laxman A. surname: Kawale fullname: Kawale, Laxman A. organization: Pharmaceutical Chemistry Department, NDMVP Samaja’s College of Pharmacy – sequence: 3 givenname: Vandana S. surname: Nade fullname: Nade, Vandana S. organization: Pharmacology Department, NDMVP Samaja’s College of Pharmacy – sequence: 4 givenname: Supriya surname: Unavane fullname: Unavane, Supriya organization: Pharmaceutical Chemistry Department, Vishwakarma University School of Pharmacy – sequence: 5 givenname: Lida surname: Sajimon fullname: Sajimon, Lida organization: Pharmacy Department, Vishwakarma University School of Pharmacy – sequence: 6 givenname: Prajakta surname: Kapadnis fullname: Kapadnis, Prajakta organization: Pharmaceutics Department, Vishwakarma University School of Pharmacy |
BookMark | eNp9UU1vEzEUtFCRKKV_gNNKXECq6fNHvNkjKpRWqtRLe0LIcuy3iaONvdibiM1_4j_WySLgUg6Wn0Yz855mXpOTEAMS8pbBR8bm6jJLAY2kwMsDxRWFF-SUCyZpzWfi5J_5FTnPeQ0AbC4lV3BKfn3G7JfhospjGFZlzheVCa7Cnem2ZvAxVLEtyE8fu3HwtjJ28Ds_jAeY0_eS9isMY9f7HpPZ-0AZHbsPlN3QBYb9N_fdb7wz-9jh0fcZyQaH1XMyh8nvyik7zG_Iy9Z0Gc9__2fk8frLw9UNvbv_env16Y5awWCgyjEzr2XbcuGcqBtgRtQWGSJXpoQFswWgaZRloBpVMyvcDB0rBCWd5U6ckdvJ10Wz1n3yG5NGHY3XRyCmpTappNGhZnyuZANoF-6Qadu4skRaY7lyaNqD17vJq0_xxxbzoNdxm0I5XwtgogEpZk1h8YllU8w5YftnKwN9aFlPLevSsj62rKGIxCTKhRyWmP5a_0f1BIoArcs |
Cites_doi | 10.1039/C2CE26120K 10.3390/70700507 10.13140/RG.2.2.25524.55684 10.1016/j.ejmech.2014.07.016 10.13040/IJPSR.0975-8232.1(1).34-38 10.1016/s0091-3057(97)00054-3 10.1016/s0169-409x(00)00129-0 10.2174/1570180819666220929121630 10.1016/j.ejmech.2009.11.053 10.1186/2191-2858-3-7 10.4103/0975-1483.66809 |
ContentType | Journal Article |
Copyright | The Author(s) 2024 The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: The Author(s) 2024 – notice: The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | C6C AAYXX CITATION 3V. 7X7 7XB 8AO 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S PHGZM PHGZT PIMPY PKEHL PQEST PQQKQ PQUKI PRINS DOA |
DOI | 10.1186/s43094-024-00626-0 |
DatabaseName | Springer Nature OA Free Journals CrossRef ProQuest Central (Corporate) ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) ProQuest Pharma Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central (subscription) ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni) ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Pharma Collection ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) |
DatabaseTitleList | Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Pharmacy, Therapeutics, & Pharmacology |
EISSN | 2314-7253 |
EndPage | 9 |
ExternalDocumentID | oai_doaj_org_article_1286490ecbd8442f9de264cac26deafd 10_1186_s43094_024_00626_0 |
GroupedDBID | 0R~ 0SF 457 5VS 6I. 7X7 8AO 8FI 8FJ AACTN AAFWJ AAKKN ABDBF ABEEZ ABMAC ABUWG ACACY ACGFS ACULB ADBBV ADEZE AFGXO AFKRA AFPKN AGHFR ALIPV ALMA_UNASSIGNED_HOLDINGS BENPR C24 C6C CCPQU EBS FDB FYUFA GROUPED_DOAJ HMCUK IAO IHR ITC KQ8 M~E O9- OK1 PIMPY RSV SOJ UKHRP AAYXX CITATION PHGZM PHGZT 3V. 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQQKQ PQUKI PRINS PUEGO |
ID | FETCH-LOGICAL-c310t-6d1a874ff23dd37901a37ce1ee26a43005b0ea96c1069671c3d5ed1e1e64dc2d3 |
IEDL.DBID | C6C |
ISSN | 2314-7253 2314-7245 |
IngestDate | Wed Aug 27 00:48:25 EDT 2025 Mon Jun 30 12:30:53 EDT 2025 Tue Jul 01 00:23:10 EDT 2025 Fri Feb 21 02:44:09 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Piperazines Benzimidazole derivatives Anti-anxiety agents Docking Health and well-being Elevated Plus Maze (EPM) test Hole board test |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c310t-6d1a874ff23dd37901a37ce1ee26a43005b0ea96c1069671c3d5ed1e1e64dc2d3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 |
ORCID | 0009-0000-1770-1100 |
OpenAccessLink | https://doi.org/10.1186/s43094-024-00626-0 |
PQID | 3013904359 |
PQPubID | 5642771 |
PageCount | 9 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_1286490ecbd8442f9de264cac26deafd proquest_journals_3013904359 crossref_primary_10_1186_s43094_024_00626_0 springer_journals_10_1186_s43094_024_00626_0 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2024-03-29 |
PublicationDateYYYYMMDD | 2024-03-29 |
PublicationDate_xml | – month: 03 year: 2024 text: 2024-03-29 day: 29 |
PublicationDecade | 2020 |
PublicationPlace | Berlin/Heidelberg |
PublicationPlace_xml | – name: Berlin/Heidelberg – name: New Cairo |
PublicationTitle | Future journal of pharmaceutical sciences |
PublicationTitleAbbrev | Futur J Pharm Sci |
PublicationYear | 2024 |
Publisher | Springer Berlin Heidelberg Springer Nature B.V SpringerOpen |
Publisher_xml | – name: Springer Berlin Heidelberg – name: Springer Nature B.V – name: SpringerOpen |
References | Unavane, Syed, Jain, Bansode (CR13) 2023; 20 Pavia, Lampman, Kirz (CR22) 2007 Bistrisky, Khalsa, Cameron, Sciffman (CR1) 2013; 38 Lipinski, Lombardo, Dominy, Feeney (CR29) 1997; 23 Venkatramana, Singh, Tiwari, Tiwari (CR8) 2010; 1 Kumar, Pathak (CR15) 2012; 1 Barua, Roy (CR24) 2009; 47 Salguirao, Ardenghi (CR5) 1997; 54 CR18 CR12 Chioua, Benabdelouahab, Chioua, Martínez (CR11) 2002; 7 Pai, Diptanshu (CR19) 2012; 2 CR30 Malik, Ahuja (CR21) 2014; 84 CR4 Nannapaneni, Gupta, Reddy (CR26) 2010; 2 Kumar, Bhat, Kumar, Shah (CR9) 2011 Walia, Hedietullah (CR10) 2011; 1 CR28 CR27 Czopek, Byrtus (CR25) 2010; 45 Jain, Jain, Sharma, Saha (CR20) 2011; 3 Rang, Dale, Riter, Flower (CR2) 2003 Xia, Wei, Yang, Qiao (CR23) 2012; 15 Barar (CR7) 2000 Foye, Lamke, Williams (CR6) 1995 Yekkirala, Sudhagani, Panuganti (CR14) 2013; 3 Petkar, Parekh, Mehta (CR17) 2013; 5 Dubey, Naidu, Anandam (CR16) 2005; 44 Tripathi (CR3) 1998 626_CR12 R Pai (626_CR19) 2012; 2 626_CR30 A Bistrisky (626_CR1) 2013; 38 K Kumar (626_CR15) 2012; 1 K Petkar (626_CR17) 2013; 5 626_CR18 R Chioua (626_CR11) 2002; 7 CC Barua (626_CR24) 2009; 47 V Yekkirala (626_CR14) 2013; 3 Z Xia (626_CR23) 2012; 15 JB Salguirao (626_CR5) 1997; 54 C Venkatramana (626_CR8) 2010; 1 R Walia (626_CR10) 2011; 1 KD Tripathi (626_CR3) 1998 DL Pavia (626_CR22) 2007 626_CR4 HP Rang (626_CR2) 2003 FS Barar (626_CR7) 2000 S Malik (626_CR21) 2014; 84 626_CR28 626_CR27 VK Jain (626_CR20) 2011; 3 D Kumar (626_CR9) 2011 PK Dubey (626_CR16) 2005; 44 SA Unavane (626_CR13) 2023; 20 DT Nannapaneni (626_CR26) 2010; 2 WO Foye (626_CR6) 1995 A Czopek (626_CR25) 2010; 45 CA Lipinski (626_CR29) 1997; 23 |
References_xml | – volume: 15 start-page: 86 year: 2012 end-page: 99 ident: CR23 article-title: Lanthanide coordination compounds with 1H-benzimidazole-2-carboxylic acid: syntheses, structures and spectroscopic properties publication-title: CrystEngComm doi: 10.1039/C2CE26120K – ident: CR18 – volume: 47 start-page: 969 year: 2009 end-page: 973 ident: CR24 article-title: Anxiolytic effect of hydroethanolic extract of L Willd publication-title: Ind J Exp Biol – volume: 2 start-page: 117 year: 2012 end-page: 128 ident: CR19 article-title: Synthesis of new analysis 3,4-dihydro-quinazolinone derivatives as a typical antidepressant, sedative, and antiparkinsons agents publication-title: J Heter Lett – volume: 7 start-page: 507 issue: 2002 year: 2002 end-page: 510 ident: CR11 article-title: Piperazine publication-title: Molecules doi: 10.3390/70700507 – ident: CR4 – year: 2011 ident: CR9 article-title: Nature: anxiolytics in the lap of nature publication-title: Webmedcentral Pharm Sci doi: 10.13140/RG.2.2.25524.55684 – ident: CR12 – ident: CR30 – year: 1998 ident: CR3 publication-title: Essential of medicinal pharmacology – volume: 84 start-page: 42 year: 2014 end-page: 50 ident: CR21 article-title: Design and synthesis of new of 3-(benzo[d]isoxazol-3-yl)-1-substituted pyrrolidine-2, 5-dione derivatives as anticonvulsants publication-title: Euro J Med Chem doi: 10.1016/j.ejmech.2014.07.016 – year: 2007 ident: CR22 publication-title: Introduction to spectroscopy – volume: 1 start-page: 34 year: 2010 end-page: 38 ident: CR8 article-title: Synthesis of phenyl hydrazine substituted benzimidazole derivatives and their biological activity publication-title: IJPSR doi: 10.13040/IJPSR.0975-8232.1(1).34-38 – volume: 54 start-page: 887 issue: 4 year: 1997 end-page: 891 ident: CR5 article-title: Anxiolytic natural and synthetic flavonoid ligands of the central benzodiazepine receptor have no effects on memory tasks in rats publication-title: Pharmacol Biochem Behav doi: 10.1016/s0091-3057(97)00054-3 – volume: 1 start-page: 44 year: 2012 end-page: 50 ident: CR15 article-title: Synthesis characterization and evaluation of 2-substituted benzimidazole derivative publication-title: Pharma Innov – ident: CR27 – volume: 5 start-page: 115 year: 2013 end-page: 119 ident: CR17 article-title: Synthesis and evaluation of 2-chloromethyl-1h-benzimidazole derivatives as antifungal agents publication-title: Int J Pharm Pharm Sci – volume: 23 start-page: 4 year: 1997 end-page: 25 ident: CR29 article-title: Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings publication-title: Adv Drug Deliv Rev doi: 10.1016/s0169-409x(00)00129-0 – volume: 20 start-page: 2025 issue: 12 year: 2023 end-page: 2033 ident: CR13 article-title: Docking and pharmacokinetic studies for screening terpenoids from erythroxylum species as anticancer agents publication-title: Lett Drug Des Discov doi: 10.2174/1570180819666220929121630 – volume: 3 start-page: 66 year: 2011 end-page: 70 ident: CR20 article-title: Synthesis characterization and antimicrobial screening of some 4-substituted 1(4substituted phenyl) piperazine derivatives publication-title: Int J Curr Pharm Res – volume: 38 start-page: 30 issue: 1 year: 2013 end-page: 38 ident: CR1 article-title: Current diagnosis and treatment of anxiety disorders publication-title: Pharm Ther – volume: 44 start-page: 1239 issue: B year: 2005 end-page: 1242 ident: CR16 article-title: Synthesis of 1- (n-hexyl-5-one)-2 chlorobenzimidazole publication-title: Ind J Chem – year: 1995 ident: CR6 publication-title: Principles of medicinal chemistry – year: 2003 ident: CR2 publication-title: Rang and dells pharmacology – volume: 45 start-page: 1295 year: 2010 end-page: 1303 ident: CR25 article-title: Synthesis and pharmacological evaluation of new 5-(cyclo) alkyl-5-phenyl- and 5-spiroimidazolidine-2,4-dione derivatives. Novel 5-HT1A receptor agonist with potential antidepressant and anxiolytic activity publication-title: Euro J Med Chem doi: 10.1016/j.ejmech.2009.11.053 – year: 2000 ident: CR7 publication-title: Essentials of pharmacotherapeutics – volume: 3 start-page: 1 year: 2013 end-page: 8 ident: CR14 article-title: Facile and efficient one-pot synthesis of benzimidazoles using lanthanum chloride publication-title: Org Med Chem Lett doi: 10.1186/2191-2858-3-7 – volume: 2 start-page: 273 year: 2010 end-page: 279 ident: CR26 article-title: Synthesis, characterization, and biological evaluation of Benzimidazole derivatives as potential anxiolytics publication-title: J Young Pharm doi: 10.4103/0975-1483.66809 – volume: 1 start-page: 3565 year: 2011 end-page: 3574 ident: CR10 article-title: Benzimidazole derivatives: an overview publication-title: IJRPC – ident: CR28 – volume-title: Principles of medicinal chemistry year: 1995 ident: 626_CR6 – ident: 626_CR18 – volume: 84 start-page: 42 year: 2014 ident: 626_CR21 publication-title: Euro J Med Chem doi: 10.1016/j.ejmech.2014.07.016 – volume: 15 start-page: 86 year: 2012 ident: 626_CR23 publication-title: CrystEngComm doi: 10.1039/C2CE26120K – ident: 626_CR12 – volume: 44 start-page: 1239 issue: B year: 2005 ident: 626_CR16 publication-title: Ind J Chem – volume: 54 start-page: 887 issue: 4 year: 1997 ident: 626_CR5 publication-title: Pharmacol Biochem Behav doi: 10.1016/s0091-3057(97)00054-3 – volume: 1 start-page: 3565 year: 2011 ident: 626_CR10 publication-title: IJRPC – volume: 38 start-page: 30 issue: 1 year: 2013 ident: 626_CR1 publication-title: Pharm Ther – volume: 23 start-page: 4 year: 1997 ident: 626_CR29 publication-title: Adv Drug Deliv Rev doi: 10.1016/s0169-409x(00)00129-0 – volume: 5 start-page: 115 year: 2013 ident: 626_CR17 publication-title: Int J Pharm Pharm Sci – year: 2011 ident: 626_CR9 publication-title: Webmedcentral Pharm Sci doi: 10.13140/RG.2.2.25524.55684 – volume: 3 start-page: 66 year: 2011 ident: 626_CR20 publication-title: Int J Curr Pharm Res – ident: 626_CR27 – volume: 1 start-page: 34 year: 2010 ident: 626_CR8 publication-title: IJPSR doi: 10.13040/IJPSR.0975-8232.1(1).34-38 – volume: 1 start-page: 44 year: 2012 ident: 626_CR15 publication-title: Pharma Innov – volume: 7 start-page: 507 issue: 2002 year: 2002 ident: 626_CR11 publication-title: Molecules doi: 10.3390/70700507 – volume: 20 start-page: 2025 issue: 12 year: 2023 ident: 626_CR13 publication-title: Lett Drug Des Discov doi: 10.2174/1570180819666220929121630 – volume: 2 start-page: 117 year: 2012 ident: 626_CR19 publication-title: J Heter Lett – volume-title: Rang and dells pharmacology year: 2003 ident: 626_CR2 – volume-title: Essential of medicinal pharmacology year: 1998 ident: 626_CR3 – volume: 47 start-page: 969 year: 2009 ident: 626_CR24 publication-title: Ind J Exp Biol – ident: 626_CR30 – volume-title: Essentials of pharmacotherapeutics year: 2000 ident: 626_CR7 – volume: 45 start-page: 1295 year: 2010 ident: 626_CR25 publication-title: Euro J Med Chem doi: 10.1016/j.ejmech.2009.11.053 – volume: 3 start-page: 1 year: 2013 ident: 626_CR14 publication-title: Org Med Chem Lett doi: 10.1186/2191-2858-3-7 – ident: 626_CR4 – ident: 626_CR28 – volume: 2 start-page: 273 year: 2010 ident: 626_CR26 publication-title: J Young Pharm doi: 10.4103/0975-1483.66809 – volume-title: Introduction to spectroscopy year: 2007 ident: 626_CR22 |
SSID | ssj0001844260 |
Score | 2.25887 |
Snippet | Background
In contemporary society, anxiety has become a widespread disorder leading to compromised well-being and heightened depressive states. Extensive... BackgroundIn contemporary society, anxiety has become a widespread disorder leading to compromised well-being and heightened depressive states. Extensive... Abstract Background In contemporary society, anxiety has become a widespread disorder leading to compromised well-being and heightened depressive states.... |
SourceID | doaj proquest crossref springer |
SourceType | Open Website Aggregation Database Index Database Publisher |
StartPage | 50 |
SubjectTerms | Anti-anxiety agents Antifungal agents Anxiety Benzimidazole derivatives Benzodiazepines Biological activity Chromatography Docking Elevated Plus Maze (EPM) test Hole board test Ligands Mass spectrometry Medicine Medicine & Public Health NMR Nuclear magnetic resonance Piperazines Proteins Scientific imaging Software Statistical analysis Well being |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3PS-QwFA7iyYvs6oqz_iCHRVacYNrEtD36Y2VYWPGgIIiEJC-FwtgZ7Oxi53_yf_QlnXF0YdjLHnpJX9LQ97X5Xpv3PUK-KeNtYBLMOeBMJsYxI8Ay4xExwnNvVchG_nWlBrfy593J3btSX2FPWCcP3N24Y3x_Kllw7yzkUqZlAR7XcGdcqsCbEsLbF9e8d8FU_LoSbBWfZ8nk6riRggcV3BQPjiye8Q8rURTs_8Ay__oxGteby09kfUYU6Wk3wc9kxdcb5OC6U5pu-_RmkTjV9OkBvV5oULeb5OUi7szo06atkeI1FdqYGuhC3JuOSmx5rkbDFoegIb8hlJEIzSn7LlnY-9UOx9UYLzOtaowB2-EhSwbM-np6Dw_VYwVmOhr6OO6SLqE-9bJugNj_E2XHmy_k9vLHzfmAzSozMId0cMIUJCbPZFmmAkBkyCmMyJxPPPrGyKCAb7k3hXIYcBYqS5yAEw8JGigJLgWxRVbrUe23Cc25M6nLLQ6XSedKk1sps8IiNUQPQtkjR3Mv6XEnwKFj4JIr3flUo0919KnmPXIWHPlmGcSzYwNCSs8gpf8FqR7ZncNAz57oRovAlTmSy6JH-nNoLE4vn9LX_zGlHbKWRuiGwnu7ZHXy9NvvIRua2P0I_Fcx8wmI priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagXLggnmKhIB9QBWKtOrHXSU4VLVQrJFAPrbQSQpZfQZGWZGm2Fdn_xH_sjDchKtJyyMWxx5Zm7Pn8mG8IeaNMsIgkmHOeM5kYx4zwlpkAFiMCD1ZhNPKXr2p-IT8vZov-wK3tn1UOa2JcqH3j8Iz8UCBW4eDci6PVL4ZZo_B2tU-hcZfcQ-oytOpskY1nLLlEAvaYXy6RLEvlbIibydVhKwVHXtwUPg64nvFbvilS-N_Cnf9clUYPdPqQPOihI_2w1fUjcifUj8nB2ZZ7upvS8zGUqp3SA3o2slJ3T8ifj_GtxpS2XQ2gr62gjqk9Hem-aVNCye-qWXYggmLEAyaWwOKUvZUMX4N1y1W1gm42VQ27wm75jiVzZkO9-ea_Vz8rbzbNMkS5O5pgxupdzTzMhutIRN4-JRenn85P5qzP1cAcAMQ1Uz4xeSbLMhXeiwxQhhGZC0kIqTISOfEtD6ZQDraghcoSJ_ws-AQqKOld6sUzslc3dXhOaM6dSV1uQVwmnStNbqXMCgtgEbTpywl5P2hJr7aUHDpuZXKltzrVoFMddar5hByjIv_WRDrtWNBc_tD97NTgpJUseHDWo8mUhYdhS2cc9BdM6SdkfzAD3c_xVo8WOSHTwTTG37uH9OL_0l6S-2k0Skyyt0_21pdX4RUgn7V9Hc37BjHVAZw priority: 102 providerName: ProQuest |
Title | Design, synthesis, and evaluation of anxiolytic activity of 2-(4-phenylpiperazin-1-yl)-1H-benz[d]imidazole and 2-(4-phenylpiperazin-1-methyl)-1H-benz[d]imidazole derivatives |
URI | https://link.springer.com/article/10.1186/s43094-024-00626-0 https://www.proquest.com/docview/3013904359 https://doaj.org/article/1286490ecbd8442f9de264cac26deafd |
Volume | 10 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3daxQxEA_agvgiWhVP65EHKYoXzG5yye6jPVsOpeWUFg5EQr4WFq57h3st7v1P_R87ye25bfEefNiFzU4-YCbkN0nmNwi9E9qbgCSItY4SnmhLNHOGaA8Wwzz1RoRo5JNTMT7nX6fDaUuTE2Jhbp_fJ5n4VHNGA3ltCg8F8E3APd8dJkyGNA0jMer2UzIeyNY3cTH_rHpn7YkU_Xdw5b2j0LjCHD9FT1poiD-vdfkMPfDVHnp00h5-76GDyZpmuhngsy5qqh7gAzzpCKib5-j6S7yWMcB1UwG-q0uQ0ZXDHbM3nhdQ8qeczxpoAofghpBDIhSn5D0n4eJXM1uUC-hmVVbgADazDyQZE-Or1U_3q7wonV7NZz62u6VKSE69rZoDw7-KnOP1C3R-fHQ2GpM2LQOxgAWXRLhEZ5IXRcqcYxIAhWbS-sT7VGge6O8N9ToXFrzNXMjEMjf0LgEBwZ1NHXuJdqp55V8hnFGrU5sZaE5yawudGc5lbgAXgjJd0UMfNwpTizX7hopeSybUWr0K1KuiehXtocOg07-SgTk7FoBBqXYiKliPBc-pt8YFiylyB8PmVlvoz-vC9dD-xiJUO51rxQJQpoAs8x4abKyk-719SK__T_wNepxGew359fbRzvL3pX8LoGdp-uihnMo-2j08Op38gK9RyvtxBvTjNgK8v33PbgBE0gEF |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKOcAF8RQLBXyACsRadRyvkxwQAkq1pQ_1sJVWQsj1KyjSkizN8sj-J_iNjJ0NUZGWWw-5OPY40ow93ziebxB6KpTTHkkQYywlPFKGqNhqohxYTOyo08JnIx8di_Ep_zAdTTfQ7y4Xxl-r7PbEsFHbyvgz8p3YYxUKzj17Pf9KfNUo_3e1K6HRmsWBa35AyFa_2t8F_T5jbO_95N2YrKoKEANQZkGEjVSa8DxnsbVxAv5QxYlxkXNMKO7Z2zV1KhMGgqVMJJGJ7cjZCDoIbg2zMci9gq6C46U-2EumSX-mk3JP-B7q2UWcJIyPujydVOzUINzz8DJ4KMQRhF7whaFkwAWc-8-v2eDx9m6iGyuoit-0tnULbbjyNto-abmumyGe9Klb9RBv45OeBbu5g37thrshQ1w3JYDMuoA-qrS4pxfHVQ4tP4tq1oAI7DMsfCEL38zIc0787bNmNi_mMM2yKCEKbWYvSDQm2pXLj_ZT8aWwalnNXJC7ZoivkL1umIXV9z0Qn9d30emlaPEe2iyr0t1HOKVGMZNqEJdwY3KVas6TTAM4BW3afIBedlqS85YCRIbQKRWy1akEncqgU0kH6K1X5N-enr47NFTnn-VqN5AACgTPqDPaepPJMwufzY0yMJ9TuR2grc4M5GpPqWW_AgZo2JlG_3r9Jz34v7Qn6Np4cnQoD_ePDx6i6ywYqC_wt4U2F-ff3CNAXQv9OJg6RmeXvbb-ALmGPmU |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLZGJyFeEFdRNiAPMIGo1cRxneQBIUZXdQyqCm3SJDQZ34IidUlZyiX9T_wBfh3HTkI0pPK2h7w49rGlc2x_x_b5DkJPmTDSIgmslPYxDYTCItQSCwMWExrfSGajkT_M2PSEvjsdnW6h320sjH1W2a6JbqHWhbJn5MPQYhUfNvdkmDbPIubjyevlV2wzSNmb1jadRm0iR6b6Ae5b-epwDLp-Rsjk4PjtFDcZBrACWLPCTAcijmiaklDrMIK9UYSRMoExhAlqmdylb0TCFDhOCYsCFeqR0QFUYFQrokOQew1tR9Yr6qHt_YPZ_GN3whNTS__ustsFFEeEjtqonZgNSxBvWXkJfD54Fdi_tDO6BAKXUO8_F7Vu_5vcQjcb4Oq9qS3tNtoy-R20N6-Zr6uBd9wFcpUDb8-bd5zY1V30a-xeigy8ssoBcpYZ1BG59jqyca9IoeRnViwqEOHZeAub1sIWE_ycYvsWrVossyV0s85y8EmrxQscTLE0-fqTPsvOMy3WxcI4uRua2HzZm5ppmIvfHQ16eQ-dXIke76NeXuTmAfJiXwmiYgniIqpUKmJJaZRIgKqgTZ320ctWS3xZE4Jw50jFjNc65aBT7nTK_T7at4r8W9OSebuC4uILb9YGDhCB0cQ3SmprMmmiYdhUCQX9GZHqPtptzYA3K0zJu_nQR4PWNLrfm4f08P_SnqDrMK_4-8PZ0Q66QZx92mx_u6i3uvhmHgEEW8nHja176PNVT68_CDdEAA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Design%2C+synthesis%2C+and+evaluation+of+anxiolytic+activity+of+2-%284-phenylpiperazin-1-yl%29-1H-benz%5Bd%5Dimidazole+and+2-%284-phenylpiperazin-1-methyl%29-1H-benz%5Bd%5Dimidazole+derivatives&rft.jtitle=Future+journal+of+pharmaceutical+sciences&rft.au=Mahajan%2C+Bhavna+Sunil&rft.au=Kawale%2C+Laxman+A.&rft.au=Nade%2C+Vandana+S.&rft.au=Unavane%2C+Supriya&rft.date=2024-03-29&rft.pub=Springer+Berlin+Heidelberg&rft.eissn=2314-7253&rft.volume=10&rft.issue=1&rft_id=info:doi/10.1186%2Fs43094-024-00626-0&rft.externalDocID=10_1186_s43094_024_00626_0 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2314-7253&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2314-7253&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2314-7253&client=summon |